Advanced Accelerator Applications, a radiopharmaceutical diagnostics company developing its first therapeutic product, postponed its IPO on Thursday due to valuation pushback.
The Saint Genis Pouilly, France-based company was founded in 2002 and booked $73 million in sales for the 12 months ended September 30, 2014. Advanced Accelerator Applications initially filed confidentially on 8/4/2014. Citi and Jefferies & Co. were set to be the joint bookrunners on the deal.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
